Epilepsy is one of the most common neurological disorders. Even though
antiepileptic drugs can afford a reasonably satisfactory treatment fo
r 80% of diagnosed patients, chronic intractable epi lepsy still affec
ts a significant number of people and more effective and less harmful
antiepileptic drugs are needed. Previous studies have shown that gamma
-decanolactone has dose-dependent sedative effects, including hypnotic
, anticonvulsant and hypothermic properties in mice. The present study
reports an inhibitory effect of gamma-decanolactone on glutamate bind
ing (96.8% with 5 mM) in rat cortex membranes. The non competitive nat
ure of glutamate binding inhibition as a neurochemical correlate of th
e anticonvulsant activity of gamma-decanolactone may be a relevant mod
e of action for further drug development.